首页>
外国专利>
RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS
RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS
展开▼
机译:RNF41作为预测非del(5q)MDS中来那度胺反应的生物标志物
展开▼
页面导航
摘要
著录项
相似文献
摘要
Disclosed herein is a method of using erythroid expression levels of RNF41 as a predictive biomarker for responsiveness to lenalidomide (LEN) in patients with non-del(5q) MDS.
展开▼